Ultima-AOD 9604

Ingredient:C-terminal fragment of the Human growth hormone

Manufacturer:Ultima Pharmaceuticals

What is Ultima-AOD?

AOD 9604 stands as a modified variant of Growth Hormone which is a peptide composed of 191 amino acids. The ultimate 15 amino acids (176-191) of the Growth Hormone polypeptide have been replicated in the form of a distinct peptide and is recognized as GH Frag 176-191 or AOD 9604.

AOD 9604 emerges as among the premier peptides for fat reduction. It similarly presents additional advantages conducive to fat decrease, heightened metabolism, and other such benefits.

Gland Stimulated: Pituitary Gland

Advantages of AOD 9604:

• Diminishes Body Fat
• Elicits fat liberation from overweight fat cells predominantly more than slender ones
• Imitates the method by which natural growth hormone governs fat metabolism
• Absence of detrimental effects on blood sugar or growth
• AOD-9604 prompts lipolysis
• Halts lipogenesis, the process of converting non-fatty foods into body fat
• AOD 9604 has showcased remarkably favorable cartilage restoration and rejuvenation properties, particularly when coupled with peptide BPC 157.

Mechanism of Operation:

AOD-9604, also denoted as Tyr-hGH Frag 176-191, has been verified to possess potent fat-burning capabilities, sans instigating a desire to overeat. It exerts no influence on blood sugar or tissue growth. AOD-9604 triggers degradation and fat burning (oxidation), utilizing a mechanism distinct from the hGH receptor. It operates through its individual mechanism of action, independent of hGH. Investigations conducted on laboratory rodents, pigs, dogs, and humans have unveiled the mechanism of AOD-9604 wherein it prompts fat release predominantly from obese fat cells and endeavors to curtail the accumulation of new fat in fat cells, while concurrently enhancing fat burning. AOD-9604’s extraordinary trait lies in its capacity to reduce abdominal fat deposits.

The second most potent peptide for fat loss is CJC-1295, given its role in heightening overall GH levels in the body (which typically diminish as individuals age). This elucidates one of the rationales behind people tending to gain fat as they age. For individuals solely targeting fat loss, it’s generally advisable to steer clear of utilizing products like GHRP (such as GHRP-6, GHRP-2, or GHRHs) as they may induce side effects like increased hunger and heightened cortisol levels. AOD-9604 does not escalate hunger or cortisol levels.

AOD 9604 Research:

AOD-9604 (Advanced Obesity Drug) was initially formulated by Professor Frank Ng at Monash University in Australia during the 1990s, with the aim of devising an anti-obesity drug that replicated the fat-burning effects of human growth hormone (HGH) without the concomitant muscle-building effect.

Recent findings have indicated that, in addition to its fat loss attributes, AOD 9604 manifests numerous other regenerative properties associated with growth hormone. Ongoing trials seek to demonstrate the application of AOD 9604 in osteoarthritis, hypercholesterolemia, bone, and cartilage repair.

Results of oral glucose tolerance tests have demonstrated that, in contrast to hGH, AOD 9604 exerts no detrimental effect on carbohydrate metabolism. No anti-AOD 9604 antibodies were detected in any of the patients subjected to antibody assays. None of the studies reported any withdrawal or serious adverse events associated with the intake of AOD 9604.

Conclusion:

AOD 9604 exhibited a highly commendable safety and tolerability profile indistinguishable from placebo. AOD 9604 did not result in any of the adverse effects associated with full-length hGH treatment. AOD 9604 boasts an excellent safety profile, recently attaining Human GRAS status in the USA.